{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:59:45Z","timestamp":1792123185756,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019559","name":"Carl von Ossietzky Universit\u00e4t Oldenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019559","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In recent decades, antidepressant utilization among young persons in Western countries has increased, raising concerns about overprescribing and safety. The COVID-19 pandemic and respective restrictions might have impacted not only youth\u2019s mental health but also antidepressant prescribing. Our aim was to systematically investigate changes in antidepressant utilization during the pandemic compared to pre-pandemic periods in European young persons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review was registered in PROSPERO (CRD42024559951). Observational studies with \u2265\u2009100 European young persons (0\u201324 years) reporting prevalence or incidence data in antidepressant utilization before and during the pandemic (2018\/2019 vs. 2021\/2022) were included and percentage changes between two time periods calculated. MEDLINE (via PubMed), PsycINFO, and EMBASE were searched from January 1, 2021 to July 3, 2024 and supplemented by citation searching. Study quality was assessed using the Joanna Briggs Institute\u2019s tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      We screened 4,416 records for eligibility and included eight studies covering data from Austria, Denmark, Finland, France, Italy, Norway, Spain, and Sweden (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094 from Nordic countries). The number of included young persons ranged from 1071 to 3,455,521 and all studies used secondary data, mostly from registries. All studies showed a relative increase in overall antidepressant use during the COVID-19 pandemic, with variability between countries ranging from 23 to 52%. Antidepressant utilization showed higher increases in adolescents (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093 studies) and females (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093 studies). Selective serotonin reuptake inhibitors were more common (73.9\u201390.9%;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093 studies) than other antidepressant classes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>During the COVID-19 pandemic, antidepressant utilization in young persons increased modestly in all studied European countries. This increase may mirror the surge in mental health problems in young persons during the pandemic, but may also reflect altered patterns of mental health services availability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00787-025-02839-x","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:44:48Z","timestamp":1755153888000},"page":"3-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Change of antidepressant utilization in children, adolescents and young adults in Europe before and during the COVID-19 pandemic: a systematic review"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-2546","authenticated-orcid":false,"given":"Alexander M.","family":"Fassmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Wandscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Bedri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Jobski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Poustka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"2839_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.600283","author":"MP Hengartner","year":"2020","unstructured":"Hengartner MP (2020) Editorial: antidepressant prescriptions in children and adolescents. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2020.600283","journal-title":"Front Psychiatry"},{"key":"2839_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-014-0631-y","author":"HC Steinhausen","year":"2015","unstructured":"Steinhausen HC (2015) Recent international trends in psychotropic medication prescriptions for children and adolescents. Eur Child Adolesc Psychiatry. https:\/\/doi.org\/10.1007\/s00787-014-0631-y","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2839_CR3","doi-asserted-by":"publisher","unstructured":"Schr\u00f6der C, D\u00f6rks M, Kollhorst B et al (2017) Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf 26. https:\/\/doi.org\/10.1002\/pds.4138","DOI":"10.1002\/pds.4138"},{"key":"2839_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60368-7","author":"V Patel","year":"2007","unstructured":"Patel V, Flisher AJ, Hetrick S, McGorry P (2007) Mental health of young people: a global public-health challenge. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(07)60368-7","journal-title":"Lancet"},{"key":"2839_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13116","author":"R Wesselhoeft","year":"2020","unstructured":"Wesselhoeft R, Jensen PB, Talati A et al (2020) Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study. Acta Psychiatr Scand. https:\/\/doi.org\/10.1111\/acps.13116","journal-title":"Acta Psychiatr Scand"},{"key":"2839_CR6","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716002099","author":"A John","year":"2016","unstructured":"John A, Marchant AL, Fone DL et al (2016) Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study. Psychol Med. https:\/\/doi.org\/10.1017\/S0033291716002099","journal-title":"Psychol Med"},{"key":"2839_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/00048674221079740","author":"J de Oliveira Costa","year":"2023","unstructured":"de Oliveira Costa J, Gillies MB, Schaffer AL et al (2023) Changes in antidepressant use in Australia: a nationwide analysis (2015\u20132021). Aust N Z J Psychiatry. https:\/\/doi.org\/10.1177\/00048674221079740","journal-title":"Aust N Z J Psychiatry"},{"key":"2839_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/S00787-018-01269-2","volume":"28","author":"T Lagerberg","year":"2019","unstructured":"Lagerberg T, Molero Y, D\u2019Onofrio BM et al (2019) Antidepressant prescription patterns and CNS polypharmacy with antidepressants among children, adolescents, and young adults: a population-based study in Sweden. Eur Child Adolesc Psychiatry 28:1137\u20131145. https:\/\/doi.org\/10.1007\/S00787-018-01269-2","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2839_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PMED.1003215","author":"RH Jack","year":"2020","unstructured":"Jack RH, Hollis C, Coupland C et al (2020) Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998\u20132017: a population-based cohort study. PLoS Med. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1003215","journal-title":"PLoS Med"},{"key":"2839_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.8656","author":"E Harris","year":"2023","unstructured":"Harris E (2023) WHO declares end of COVID-19 global health emergency. JAMA. https:\/\/doi.org\/10.1001\/jama.2023.8656","journal-title":"JAMA"},{"key":"2839_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02143-7","author":"DF Santomauro","year":"2021","unstructured":"Santomauro DF, Mantilla Herrera AM, Shadid J et al (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(21)02143-7","journal-title":"Lancet"},{"key":"2839_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.975936","author":"CSM Ng","year":"2022","unstructured":"Ng CSM, Ng SSL (2022) Impact of the COVID-19 pandemic on children\u2019s mental health: a systematic review. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2022.975936","journal-title":"Front Psychiatry"},{"key":"2839_CR13","doi-asserted-by":"publisher","unstructured":"Bliddal M, Rasmussen L, Andersen JH et al (2023) Psychotropic medication use and psychiatric disorders during the COVID-19 pandemic among Danish children, adolescents, and young adults. JAMA Psychiatry 80. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.4165","DOI":"10.1001\/jamapsychiatry.2022.4165"},{"key":"2839_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19084782","author":"MDC Gonz\u00e1lez-L\u00f3pez","year":"2022","unstructured":"Gonz\u00e1lez-L\u00f3pez MDC, D\u00edaz-Calvo V, Ru\u00edz-Gonz\u00e1lez C et al (2022) Consumption of psychiatric drugs in primary care during the COVID-19 pandemic. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph19084782","journal-title":"Int J Environ Res Public Health"},{"key":"2839_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-023-02574-1","author":"T Vuki\u0107evi\u0107","year":"2024","unstructured":"Vuki\u0107evi\u0107 T, Dragani\u0107 P, \u0160kribulja M et al (2024) Consumption of psychotropic drugs in Croatia before and during the COVID-19 pandemic: a 10-year longitudinal study (2012\u20132021). Soc Psychiatry Psychiatr Epidemiol. https:\/\/doi.org\/10.1007\/s00127-023-02574-1","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2839_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/acps.13719","volume":"150","author":"H Kildegaard","year":"2024","unstructured":"Kildegaard H, Wesselhoeft R, Lund LC, Bliddal M (2024) Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adults. Acta Psychiatr Scand 150:174\u2013177. https:\/\/doi.org\/10.1111\/acps.13719","journal-title":"Acta Psychiatr Scand"},{"key":"2839_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.11.068","author":"M Tiger","year":"2023","unstructured":"Tiger M, Wesselhoeft R, Karlsson P et al (2023) Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. J Affect Disord. https:\/\/doi.org\/10.1016\/j.jad.2022.11.068","journal-title":"J Affect Disord"},{"key":"2839_CR18","doi-asserted-by":"publisher","unstructured":"Munn Z, Moola S, Lisy K et al (2020) Chap. 5: systematic reviews of prevalence and incidence. In: Aromataris E, Munn Z (eds) JBI Manual for Evidence Synthesis. https:\/\/doi.org\/10.46658\/jbirm-17-05","DOI":"10.46658\/jbirm-17-05"},{"key":"2839_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol 134:178\u2013189. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.03.001","journal-title":"J Clin Epidemiol"},{"key":"2839_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","volume":"7","author":"X Zhou","year":"2020","unstructured":"Zhou X, Teng T, Zhang Y et al (2020) Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 7:581\u2013601. https:\/\/doi.org\/10.1016\/S2215-0366(20)30137-1","journal-title":"Lancet Psychiatry"},{"key":"2839_CR21","doi-asserted-by":"publisher","unstructured":"Hetrick SE, McKenzie JE, Bailey AP et al (2021) New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev 5. https:\/\/doi.org\/10.1002\/14651858.CD013674.PUB2","DOI":"10.1002\/14651858.CD013674.PUB2"},{"key":"2839_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/ACPS.12644","volume":"135","author":"K Jobski","year":"2017","unstructured":"Jobski K, H\u00f6fer J, Hoffmann F, Bachmann C (2017) Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatr Scand 135:8\u201328. https:\/\/doi.org\/10.1111\/ACPS.12644","journal-title":"Acta Psychiatr Scand"},{"key":"2839_CR23","doi-asserted-by":"publisher","unstructured":"Torbahn G, Brauchmann J, Axon E et al (2022) Surgery for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev 2022. https:\/\/doi.org\/10.1002\/14651858.CD011740.pub2","DOI":"10.1002\/14651858.CD011740.pub2"},{"key":"2839_CR24","doi-asserted-by":"publisher","unstructured":"Storeb\u00f8 OJ, Storm MRO, Pereira Ribeiro J et al (2023) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 2023. https:\/\/doi.org\/10.1002\/14651858.CD009885.pub3","DOI":"10.1002\/14651858.CD009885.pub3"},{"key":"2839_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, MClinSc SM, Lisy K et al (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 13:147\u2013153. https:\/\/doi.org\/10.1097\/XEB.0000000000000054","journal-title":"Int J Evid Based Healthc"},{"key":"2839_CR26","unstructured":"United Nations Statistical Office (1999) Methodology Standard country or area codes for statistical use (M49). Geographic Regions. https:\/\/unstats.un.org\/unsd\/methodology\/m49\/. Accessed 9 Jul 2024"},{"key":"2839_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1186\/S12913-024-11671-Z\/FIGURES\/3","volume":"24","author":"GH Rees","year":"2024","unstructured":"Rees GH, Batenburg R, Scotter C (2024) Responding to COVID-19: an exploration of EU country responses and directions for further research. BMC Health Serv Res 24:1198. https:\/\/doi.org\/10.1186\/S12913-024-11671-Z\/FIGURES\/3","journal-title":"BMC Health Serv Res"},{"key":"2839_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.708496","author":"H Chen","year":"2021","unstructured":"Chen H, Shi L, Zhang Y et al (2021) Response to the COVID-19 pandemic: comparison of strategies in six countries. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2021.708496","journal-title":"Front Public Health"},{"key":"2839_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21844-7","author":"LM Rossen","year":"2022","unstructured":"Rossen LM, N\u00f8rgaard SK, Sutton PD et al (2022) Excess all-cause mortality in the USA and Europe during the COVID-19 pandemic, 2020 and 2021. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-21844-7","journal-title":"Sci Rep"},{"key":"2839_CR30","unstructured":"United Nations Youth https:\/\/www.un.org\/en\/global-issues\/youth#:~:text=WhoAretheYouth%3F,of15and24years. Accessed 9 Jul 2024"},{"key":"2839_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"2839_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy12010021","author":"LG Armando","year":"2024","unstructured":"Armando LG, Baroetto Parisi R, Rolando C et al (2024) Impact of the COVID-19 pandemic on the use of antidepressants by young adults in the ASL TO4 Regione Piemonte (Italy). Pharmacy (Basel). https:\/\/doi.org\/10.3390\/pharmacy12010021","journal-title":"Pharmacy (Basel)"},{"key":"2839_CR33","doi-asserted-by":"publisher","unstructured":"Bojani\u0107 I (2024) Use of antidepressant and anxiolytic drugs in Scandinavian countries between 2006 and 2021: A prescription database study. Depress Anxiety 2024. https:\/\/doi.org\/10.1155\/2024\/5448587","DOI":"10.1155\/2024\/5448587"},{"key":"2839_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15360-0","author":"MLN Garc\u00eda","year":"2023","unstructured":"Garc\u00eda MLN, Mart\u00ednez PF, Bret\u00f3n EF et al (2023) Psychotropic consumption before and during COVID-19 in Asturias, Spain. BMC Public Health. https:\/\/doi.org\/10.1186\/s12889-023-15360-0","journal-title":"BMC Public Health"},{"key":"2839_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13483","author":"I Kuitunen","year":"2022","unstructured":"Kuitunen I (2022) Psychotropic medication use in pediatric population during COVID-19 pandemic. Acta Psychiatr Scand. https:\/\/doi.org\/10.1111\/acps.13483","journal-title":"Acta Psychiatr Scand"},{"key":"2839_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-023-00584-0","author":"I Kuitunen","year":"2023","unstructured":"Kuitunen I, Uimonen MM, Ponkilainen VT, Mattila VM (2023) Primary care visits due to mental health problems and use of psychotropic medication during the COVID-19 pandemic in Finnish adolescents and young adults. Child Adolesc Psychiatry Ment Health. https:\/\/doi.org\/10.1186\/s13034-023-00584-0","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"2839_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-023-00684-x","author":"M Otter","year":"2024","unstructured":"Otter M, Kothgassner OD, Lepusch\u00fctz L et al (2024) The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in Austria. Child Adolesc Psychiatry Ment Health. https:\/\/doi.org\/10.1186\/s13034-023-00684-x","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"2839_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.13046","author":"E Pedersen","year":"2024","unstructured":"Pedersen E, Tripodi E, Aakj\u00e6r M et al (2024) Drug utilisation in children and adolescents before and after the start of the COVID-19 pandemic: interrupted time-series analyses in three European countries. Paediatr Perinat Epidemiol. https:\/\/doi.org\/10.1111\/ppe.13046","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2839_CR39","doi-asserted-by":"publisher","first-page":"e247965","DOI":"10.1001\/jamanetworkopen.2024.7965","volume":"7","author":"Z Valtuille","year":"2024","unstructured":"Valtuille Z, Acquaviva E, Trebossen V et al (2024) Psychotropic medication prescribing for children and adolescents after the onset of the COVID-19 pandemic. JAMA Netw Open 7:e247965\u2013e247965. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.7965","journal-title":"JAMA Netw Open"},{"key":"2839_CR40","doi-asserted-by":"publisher","first-page":"e078384","DOI":"10.1136\/bmj-2023-078384","volume":"385","author":"J Hirt","year":"2024","unstructured":"Hirt J, Nordhausen T, Fuerst T et al (2024) Guidance on terminology, application, and reporting of citation searching: the tarcis statement. BMJ 385:e078384. https:\/\/doi.org\/10.1136\/bmj-2023-078384","journal-title":"BMJ"},{"key":"2839_CR41","unstructured":"Statistics Denmark (2025) StatBank Denmark: People. https:\/\/www.statbank.dk\/20021"},{"key":"2839_CR42","unstructured":"Statistikdatabasen (2025) Folkm\u00e4ngden efter \u00e5lder och k\u00f6n. \u00c5r 1860\u20132024. PxWeb. https:\/\/www.statistikdatabasen.scb.se\/pxweb\/sv\/ssd\/START__BE__BE0101__BE0101A\/BefolkningR1860N\/. Accessed 13 Mar 2025"},{"key":"2839_CR43","unstructured":"Instituto Nacional de Estad\u00edstica (2025) Resident population by date, sex, age group and country of birth (groups of countries). https:\/\/www.ine.es\/jaxiT3\/Datos.htm?t=69794. Accessed 13 Mar 2025"},{"key":"2839_CR44","unstructured":"Tilastokeskus (Tilastokeskuksen maksuttomat tilastotietokannat) (2025) PxWeb - StatFin. https:\/\/pxdata.stat.fi\/PxWeb\/pxweb\/fi\/StatFin\/. Accessed 13 Mar 2025"},{"key":"2839_CR45","unstructured":"STATISTIK AUSTRIA - Die Informationsmanager (2025) Bev\u00f6lkerung nach Alter\/Geschlecht. https:\/\/www.statistik.at\/statistiken\/bevoelkerung-und-soziales\/bevoelkerung\/bevoelkerungsstand\/bevoelkerung-nach-alter\/geschlecht. Accessed 13 Mar 2025"},{"key":"2839_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/J.LANEPE.2022.100368\/ATTACHMENT\/3A1441AA-0F6A-4E54-811F-8255374B9C45\/MMC2.DOCX","author":"S Chen","year":"2022","unstructured":"Chen S, Ford TJ, Jones PB, Cardinal RN (2022) Prevalence, progress, and subgroup disparities in Pharmacological antidepressant treatment of those who screen positive for depressive symptoms: A repetitive cross-sectional study in 19 European countries. Lancet Reg Heal - Eur. https:\/\/doi.org\/10.1016\/J.LANEPE.2022.100368\/ATTACHMENT\/3A1441AA-0F6A-4E54-811F-8255374B9C45\/MMC2.DOCX. 17:100368","journal-title":"Lancet Reg Heal - Eur"},{"key":"2839_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.JPSYCHIRES.2019.08.009","volume":"118","author":"H He","year":"2019","unstructured":"He H, Xiang Y, Gao F et al (2019) Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: a network meta-analysis. J Psychiatr Res 118:21\u201330. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2019.08.009","journal-title":"J Psychiatr Res"},{"key":"2839_CR48","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/S00787-022-02131-2","volume":"33","author":"R Sacco","year":"2022","unstructured":"Sacco R, Camilleri N, Eberhardt J et al (2022) A systematic review and meta-analysis on the prevalence of mental disorders among children and adolescents in Europe. Eur Child Adolesc Psychiatry 33:2877. https:\/\/doi.org\/10.1007\/S00787-022-02131-2","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2839_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/S41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M et al (2022) Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry 27:281\u2013295. https:\/\/doi.org\/10.1038\/S41380-021-01161-7","journal-title":"Mol Psychiatry"},{"key":"2839_CR50","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/JAMAPEDIATRICS.2021.2482","volume":"175","author":"N Racine","year":"2021","unstructured":"Racine N, McArthur BA, Cooke JE et al (2021) Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr 175:1142\u20131150. https:\/\/doi.org\/10.1001\/JAMAPEDIATRICS.2021.2482","journal-title":"JAMA Pediatr"},{"key":"2839_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/FPUBH.2021.793868","volume":"9","author":"L Marciano","year":"2022","unstructured":"Marciano L, Ostroumova M, Schulz PJ, Camerini AL (2022) Digital media use and adolescents\u2019 mental health during the Covid-19 pandemic: a systematic review and meta-analysis. Front Public Health 9:793868. https:\/\/doi.org\/10.3389\/FPUBH.2021.793868","journal-title":"Front Public Health"},{"key":"2839_CR52","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2215-0366(17)30127-X","volume":"4","author":"G Signorini","year":"2017","unstructured":"Signorini G, Singh SP, Boricevic-Marsanic V et al (2017) Architecture and functioning of child and adolescent mental health services: a 28-country survey in Europe. Lancet Psychiatry 4:715\u2013724. https:\/\/doi.org\/10.1016\/S2215-0366(17)30127-X","journal-title":"Lancet Psychiatry"},{"key":"2839_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2022.2065190","author":"B Wang","year":"2022","unstructured":"Wang B, Feldman I, Chkonia E et al (2022) Mental health services in Scandinavia and Eurasia: comparison of financing and provision. Int Rev Psychiatry. https:\/\/doi.org\/10.1080\/09540261.2022.2065190","journal-title":"Int Rev Psychiatry"},{"key":"2839_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15061133","author":"M Sadeniemi","year":"2018","unstructured":"Sadeniemi M, Almeda N, Salinas-P\u00e9rez JA et al (2018) A comparison of mental health care systems in Northern and Southern Europe: a service mapping study. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph15061133","journal-title":"Int J Environ Res Public Health"},{"key":"2839_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/S00787-024-02472-0","author":"Y Mori","year":"2024","unstructured":"Mori Y, Sourander A, Mishina K et al (2024) Unmet need for mental health care among adolescents in Asia and Europe. Eur Child Adolesc Psychiatry. https:\/\/doi.org\/10.1007\/S00787-024-02472-0","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2839_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/08039488.2022.2105946","volume":"77","author":"L Hellstr\u00f6m","year":"2023","unstructured":"Hellstr\u00f6m L, Gren Voldby K, Eplov LF (2023) Stigma towards people with mental illness in the Nordic countries - a scoping review. Nord J Psychiatry 77:319\u2013328. https:\/\/doi.org\/10.1080\/08039488.2022.2105946","journal-title":"Nord J Psychiatry"},{"key":"2839_CR57","unstructured":"Nyzio C (2021) Mental health in italy: systems, stigma, and impact of COVID-19. CISLA Sr Integr Proj. https:\/\/digitalcommons.conncoll.edu\/cgi\/viewcontent.cgi?article=1034&context=sip"},{"key":"2839_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44220-024-00371-6","volume":"2025","author":"LY Atlas","year":"2025","unstructured":"Atlas LY, Farmer C, Shaw JS et al (2025) Dynamic effects of psychiatric vulnerability, loneliness and isolation on distress during the first year of the COVID-19 pandemic. Nat Ment Heal 2025:1\u201313. https:\/\/doi.org\/10.1038\/s44220-024-00371-6","journal-title":"Nat Ment Heal"},{"key":"2839_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14088-7","author":"F Cascini","year":"2022","unstructured":"Cascini F, Failla G, Gobbi C et al (2022) A cross-country comparison of Covid-19 containment measures and their effects on the epidemic curves. BMC Public Health. https:\/\/doi.org\/10.1186\/s12889-022-14088-7","journal-title":"BMC Public Health"},{"key":"2839_CR60","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-064245","author":"KP Chua","year":"2024","unstructured":"Chua KP, Volerman A, Zhang J et al (2024) Antidepressant dispensing to US adolescents and young adults: 2016\u20132022. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2023-064245","journal-title":"Pediatrics"},{"key":"2839_CR61","doi-asserted-by":"publisher","unstructured":"Antoniou T, Pajer K, Gardner W et al (2023) Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study. Front Pediatr 11. https:\/\/doi.org\/10.3389\/fped.2023.1282845","DOI":"10.3389\/fped.2023.1282845"},{"key":"2839_CR62","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51948","author":"SJ Wood","year":"2023","unstructured":"Wood SJ, Ilom\u00e4ki J, Gould J et al (2023) Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID-19 pandemic, 2013\u20132021: a retrospective cohort study. Med J Aust. https:\/\/doi.org\/10.5694\/mja2.51948","journal-title":"Med J Aust"},{"key":"2839_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5694\/MJA2","volume":"219","author":"RA Hardie","year":"2023","unstructured":"Hardie RA, Sezgin G, Pont LG et al (2023) Psychotropic medication prescribing for children and adolescents by general practitioners during the COVID-19 pandemic. Med J Aust 219:26\u201327. https:\/\/doi.org\/10.5694\/MJA251942;CTYPE:STRING:JOURNAL","journal-title":"Med J Aust"},{"key":"2839_CR64","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/J.EURONEURO.2016.02.001","volume":"26","author":"CJ Bachmann","year":"2016","unstructured":"Bachmann CJ, Aagaard L, Burcu M et al (2016) Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005\u20132012. Eur Neuropsychopharmacol 26:411\u2013419. https:\/\/doi.org\/10.1016\/J.EURONEURO.2016.02.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2839_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101105","volume":"47","author":"Y Yang","year":"2024","unstructured":"Yang Y, Fang F, Arnberg FK et al (2024) Sex differences in clinically diagnosed psychiatric disorders over the lifespan: a nationwide register-based study in Sweden. Lancet Reg Health 47:101105. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101105","journal-title":"Lancet Reg Health"},{"key":"2839_CR66","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/JAMAPEDIATRICS.2023.0846","volume":"177","author":"S Madigan","year":"2023","unstructured":"Madigan S, Racine N, Vaillancourt T et al (2023) Changes in depression and anxiety among children and adolescents from before to during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Pediatr 177:567\u2013581. https:\/\/doi.org\/10.1001\/JAMAPEDIATRICS.2023.0846","journal-title":"JAMA Pediatr"},{"key":"2839_CR67","doi-asserted-by":"publisher","first-page":"e889","DOI":"10.1016\/S2468-2667(23)00220-7","volume":"8","author":"J Arias-de la Torre","year":"2023","unstructured":"Arias-de la Torre J, Vilagut G, Ronaldson A et al (2023) Prevalence and variability of depressive symptoms in europe: update using representative data from the second and third waves of the European health interview survey (EHIS-2 and EHIS-3). Lancet Public Heal 8:e889\u2013e898. https:\/\/doi.org\/10.1016\/S2468-2667(23)00220-7","journal-title":"Lancet Public Heal"},{"key":"2839_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/J.LANEPE.2022.100368","author":"S Chen","year":"2022","unstructured":"Chen S, Ford TJ, Jones PB, Cardinal RN (2022) Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: a repetitive cross-sectional study in 19 European countries. Lancet Reg Health. https:\/\/doi.org\/10.1016\/J.LANEPE.2022.100368","journal-title":"Lancet Reg Health"},{"key":"2839_CR69","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7024e1","author":"E Yard","year":"2021","unstructured":"Yard E, Radhakrishnan L, Ballesteros MF et al (2021) Emergency department visits for suspected suicide attempts among persons aged 12\u201325 years before and during the COVID-19 pandemic \u2014 United states, January 2019\u2013May 2021. MMWR Morb Mortal Wkly Rep. https:\/\/doi.org\/10.15585\/mmwr.mm7024e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2839_CR70","doi-asserted-by":"publisher","first-page":"e2441874","DOI":"10.1001\/JAMANETWORKOPEN.2024.41874","volume":"7","author":"Z Valtuille","year":"2024","unstructured":"Valtuille Z, Trebossen V, Ouldali N et al (2024) Pediatric hospitalizations and emergency department visits related to mental health conditions and Self-Harm. JAMA Netw Open 7:e2441874\u2013e2441874. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2024.41874","journal-title":"JAMA Netw Open"},{"key":"2839_CR71","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/J.JAD.2019.01.039","volume":"249","author":"A Gomez-Lumbreras","year":"2019","unstructured":"Gomez-Lumbreras A, Ferrer P, Ballar\u00edn E et al (2019) Study of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use? J Affect Disord 249:278\u2013285. https:\/\/doi.org\/10.1016\/J.JAD.2019.01.039","journal-title":"J Affect Disord"},{"key":"2839_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/JCP.0000000000000891","volume":"38","author":"A Revet","year":"2018","unstructured":"Revet A, Montastruc F, Raynaud JP et al (2018) Trends and patterns of antidepressant use in French children and adolescents from 2009 to 2016: a population-based study in the French health insurance database. J Clin Psychopharmacol 38:327\u2013335. https:\/\/doi.org\/10.1097\/JCP.0000000000000891","journal-title":"J Clin Psychopharmacol"},{"key":"2839_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/S00787-024-02433-7","author":"L Rasmussen","year":"2024","unstructured":"Rasmussen L, Jensen PB, Reutfors J et al (2024) Treatment patterns of antidepressants in children and adolescents in Scandinavia. Eur Child Adolesc Psychiatry. https:\/\/doi.org\/10.1007\/S00787-024-02433-7","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2839_CR74","unstructured":"Socialstyrelsen Nationella riktlinjer depression och \u00e5ngestsyndrom - Socialstyrelsen. https:\/\/www.socialstyrelsen.se\/kunskapsstod-och-regler\/regler-och-riktlinjer\/nationella-riktlinjer\/riktlinjer-och-utvarderingar\/depression-och-angest\/. Accessed 28 Jan 2025"},{"key":"2839_CR75","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","volume":"8","author":"R Brauer","year":"2021","unstructured":"Brauer R, Alfageh B, Blais JE et al (2021) Psychotropic medicine consumption in 65 countries and regions, 2008\u201319: a longitudinal study. Lancet Psychiatry 8:1071\u20131082. https:\/\/doi.org\/10.1016\/S2215-0366(21)00292-3","journal-title":"Lancet Psychiatry"},{"key":"2839_CR76","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/J.JAD.2022.02.001","volume":"303","author":"LF Camacho-Arteaga","year":"2022","unstructured":"Camacho-Arteaga LF, Gardarsdottir H, Iba\u00f1ez L et al (2022) Indications related to antidepressant prescribing in the Nivel-PCD database and the SIDIAP database. J Affect Disord 303:131\u2013137. https:\/\/doi.org\/10.1016\/J.JAD.2022.02.001","journal-title":"J Affect Disord"},{"key":"2839_CR77","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3748\/WJG.15.1548","volume":"15","author":"R Rahimi","year":"2009","unstructured":"Rahimi R, Nikfar S, Rezale A, Abdollahi M (2009) Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 15:1548. https:\/\/doi.org\/10.3748\/WJG.15.1548","journal-title":"World J Gastroenterol"},{"key":"2839_CR78","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/JOURNAL.PMED.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A et al (2015) The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med 12:e1001885. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1001885","journal-title":"PLoS Med"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-025-02839-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:30:48Z","timestamp":1771425048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-025-02839-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2839"],"URL":"https:\/\/doi.org\/10.1007\/s00787-025-02839-x","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}